Viatris (VIA) Stock Forecast & Price Target

13 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

VIA Analyst Ratings

Moderate Buy

3 Buy

3 Hold

1 Sell

Based on 7 analysts giving stock ratings to

Viatris

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

VIA Stock 12 Month Forecast

Average Price Target

€15.99

▲(5.64% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Viatris in the last 3 months. The average price target is €15.99 with a high forecast of €19.96 and a low forecast of €10.41. The average price target represents a 5.64% change from the last price of €15.14.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"€6","13":"€13","20":"€20","9.5":"€9.5","16.5":"€16.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":19.96124046,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€19.96</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.993788940000002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€15.99</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.41456024,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€10.41</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,9.5,13,16.5,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.236,15.599480035384616,15.962960070769231,16.326440106153846,16.68992014153846,17.053400176923077,17.416880212307692,17.780360247692307,18.143840283076923,18.507320318461538,18.870800353846153,19.23428038923077,19.597760424615384,{"y":19.96124046,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.236,15.294291456923078,15.352582913846154,15.410874370769232,15.469165827692308,15.527457284615386,15.585748741538463,15.64404019846154,15.702331655384617,15.760623112307695,15.81891456923077,15.877206026153848,15.935497483076924,{"y":15.993788940000002,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.236,14.865120018461539,14.494240036923077,14.123360055384616,13.752480073846154,13.381600092307693,13.010720110769231,12.63984012923077,12.268960147692308,11.898080166153846,11.527200184615385,11.156320203076923,10.785440221538462,{"y":10.41456024,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.318,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.579,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.427,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":8.786,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.055,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.374,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.201,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.613,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.703,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.815,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.648,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.308,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.236,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€19.96

Average Price Target€15.99

Lowest Price Target€10.41

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ashwani Verma

UBS

€19.96

Buy

31.84%

Upside

Reiterated

08/07/26

Analysts Offer Insights on Healthcare Companies: Warby Parker (NYSE: WRBY), Viatris (NASDAQ: VTRS) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)

Salveen Richter

Goldman Sachs

€15.62→€17.36

Hold

14.65%

Upside

Reiterated

08/06/26

Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS), Immunocore Holdings (NASDAQ: IMCR) and Praxis Precision Medicines (NASDAQ: PRAX)

Chris Schott

J.P. Morgan

€15.62

Hold

3.18%

Upside

Reiterated

07/28/26

J.P. Morgan Sticks to Its Hold Rating for Viatris (VTRS)

Jason Gerberry

Bank of America Securities

€12.15

Sell

-19.75%

Downside

Reiterated

07/10/26

Bank of America Securities Keeps Their Sell Rating on Viatris (VTRS)

David Amsellem

Piper Sandler

€10.41

Hold

-31.21%

Downside

Reiterated

06/04/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Viatris (NASDAQ: VTRS), Medtronic (NYSE: MDT) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Glen Santangelo

Barclays

€14.75→€19.09

Buy

26.11%

Upside

Assigned

05/18/26

Barclays Remains a Buy on Viatris (VTRS)

Les Sulewski

Truist Financial

€15.62→€17.36

Buy

14.65%

Upside

Reiterated

05/08/26

Viatris (VTRS) Gets a Buy from Truist Financial

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€14.75

Buy

-2.55%

Downside

Reiterated

03/20/26

Jefferies Keeps Their Buy Rating on Viatris (VTRS)

John Eade

Argus Research

€13.02

Buy

-14.01%

Downside

Upgraded

01/16/26

Viatris upgraded to Buy from Hold at ArgusViatris upgraded to Buy from Hold at Argus

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ashwani Verma

UBS

€19.96

Buy

31.84%

Upside

Reiterated

08/07/26

Analysts Offer Insights on Healthcare Companies: Warby Parker (NYSE: WRBY), Viatris (NASDAQ: VTRS) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)

Salveen Richter

Goldman Sachs

€15.62→€17.36

Hold

14.65%

Upside

Reiterated

08/06/26

Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS), Immunocore Holdings (NASDAQ: IMCR) and Praxis Precision Medicines (NASDAQ: PRAX)

Chris Schott

J.P. Morgan

€15.62

Hold

3.18%

Upside

Reiterated

07/28/26

J.P. Morgan Sticks to Its Hold Rating for Viatris (VTRS)

Jason Gerberry

Bank of America Securities

€12.15

Sell

-19.75%

Downside

Reiterated

07/10/26

Bank of America Securities Keeps Their Sell Rating on Viatris (VTRS)

David Amsellem

Piper Sandler

€10.41

Hold

-31.21%

Downside

Reiterated

06/04/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Viatris (NASDAQ: VTRS), Medtronic (NYSE: MDT) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Glen Santangelo

Barclays

€14.75→€19.09

Buy

26.11%

Upside

Assigned

05/18/26

Barclays Remains a Buy on Viatris (VTRS)

Les Sulewski

Truist Financial

€15.62→€17.36

Buy

14.65%

Upside

Reiterated

05/08/26

Viatris (VTRS) Gets a Buy from Truist Financial

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€14.75

Buy

-2.55%

Downside

Reiterated

03/20/26

Jefferies Keeps Their Buy Rating on Viatris (VTRS)

John Eade

Argus Research

€13.02

Buy

-14.01%

Downside

Upgraded

01/16/26

Viatris upgraded to Buy from Hold at ArgusViatris upgraded to Buy from Hold at Argus

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Viatris

3 Months

Les SulewskiTruist Financial

Success Rate

7/8 ratings generated profit

Average Return

+19.71%

Copying Les Sulewski's trades and holding each position for 3 Months would result in 87.50% of your transactions generating a profit, with an average return of +19.71% per trade.

1 Year

Les SulewskiTruist Financial

Success Rate

7/8 ratings generated profit

Average Return

+33.17%

Copying Les Sulewski's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +33.17% per trade.

2 Years

Les SulewskiTruist Financial

Success Rate

7/8 ratings generated profit

Average Return

+33.17%

Copying Les Sulewski's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +33.17% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VIA Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, VIA has received 2 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. VIA average Analyst price target in the past 3 months is 15.99.

Each month's total comprises the sum of three months' worth of ratings.

VIA Financial Forecast

VIA Earnings Forecast

Next quarter’s earnings estimate for VIA is €0.56 with a range of €0.54 to €0.59. The previous quarter’s EPS was €0.60. VIA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year VIA has Performed in-line its overall industry.

VIA Sales Forecast

Next quarter’s sales forecast for VIA is €3.31B with a range of €3.25B to €3.36B. The previous quarter’s sales results were €3.26B. VIA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year VIA has Performed in-line its overall industry.

VIA Stock Forecast FAQ

What is DE:VIA’s average 12-month price target, according to analysts?

Based on analyst ratings, Viatris, Inc.’s 12-month average price target is 15.99.

What is DE:VIA’s upside potential, based on the analysts’ average price target?

Viatris, Inc. has 5.64% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Viatris, Inc. a Buy, Sell or Hold?

Viatris, Inc. has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 3 hold ratings and 1 sell ratings.

What is Viatris, Inc.’s share price target?

The average share price target for Viatris, Inc. is 15.99. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €19.96 ,and the lowest forecast is €10.41. The average share price target represents 5.64% Increase from the current price of €15.14.

What do analysts say about Viatris, Inc.?

Viatris, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of Viatris, Inc.?

To buy shares of DE:VIA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Viatris (VIA) Stock Forecast & Price Target

VIA Analyst Ratings

VIA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Viatris

VIA Analyst Recommendation Trends

VIA Financial Forecast

VIA Earnings Forecast

VIA Sales Forecast

VIA Stock Forecast FAQ

Detailed List of Analyst Forecasts